Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Dr John Kimoff
With
Canadian Institutes of Health Research (CIHR)
ResMed Canada Inc.
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
≥ 18 y with a singleton pregnancy, ≥ 12 weeks' gestation
diagnosis of hypertensive disorder of pregnancy, including pre-existing hypertension, gestational hypertension and pre-eclampsia, as defined by Canadian Hypertensive Disorders of Pregnancy Working Group Criteria (Magee et al; Best Practice and Research Clinical obstetrics \& Gynaecology. 2015;29(5):643-657)
presence of obstructive sleep-disordered breathing (OSDB) on a single night in-home complete (Level 2) polysomnogram defined by an apnea-hypopnea index (AHI) ≥ 5 events/h and/or the presence of inspiratory flow limitation on ≥ 30% of breaths.
You may not be if
severe pre-eclampsia/eclampsia requiring urgent delivery
chronic kidney disease or other secondary cause of hypertension
known cardiac disease, transient ischemic attack/stroke
malignancy or other chronic medical or psychiatric condition
smoking, alcohol use, illicit drugs
current/recent treatment for sleep-disordered breathing
severe sleep-disordered breathing defined as an apnea-hypopnea index (AHI) ≥ 30/h with either severe sleepiness (Epworth sleepiness score ≥ 15) or hypoxemia (4% Oxygen Desaturation Index ≥30/h or arterial oxygen saturation (SpO2) \<80% for \>10% of Total Sleep Time)
Clareo Health | Positive Airway Pressure Treatment of Obstructive Sleep-disordered Breathing in Hypertensive Disorders of Pregnancy
